Oral Octreotide Shows Promise as Alternative to Injections for Acromegaly

Many patients with acromegaly may do as well on oral octreotide treatment as they do on injectable somatostatin receptor ligands, an industry-sponsored phase 3 trial suggests.
Reuters Health Information

source https://www.medscape.com/viewarticle/966233?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?